High-volume versus standard-volume haemofiltration for septic shock patients with acute kidney injury (IVOIRE study): A multicentre randomized controlled trial

Intensive Care Medicine

Volumn 39, Issue 9, 2013, Pages 1535-1546

  Joannes Boyau, Olivier ^a,n   Honoré, Patrick M ^b   Perez, Paul ^a   Bagshaw, Sean M ^c   Grand, Hubert ^d   Canivet, Jean Luc ^e   Dewitte, Antoine ^a   Flamens, Claire ^f   Pujol, Wilfried ^g   Grandoulier, Anne Sophie ^a   Fleureau, Catherine ^a   Jacobs, Rita ^b   Broux, Christophe ^h   Floch, Hervé ⁱ   Branchard, Olivier ^a   Franck, Stephane ^j   Rozé, Hadrien ^a   Collin, Vincent ^k   Boer, Willem ^l   Calderon, Joachim ^a   Gauche, Bernard ^d   Spapen, Herbert D ^b   Janvier, Gérard ^a,m   Ouattara, Alexandre ^a,m   more..

^a BORDEAUX UNIVERSITY HOSPITAL   (France)

^b UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

^c UNIVERSITY OF ALBERTA   (Canada)

^d hôpital Robert Boulin   (France)

^e UNIVERSITY OF LIÈGE   (Belgium)

^f LOUIS PRADEL HOSPITAL   (France)

^g Clinique Bordeaux Nord   (France)

^h HÔPITAL MICHALLON   (France)

ⁱ BREST UNIVERSITY HOSPITAL   (France)

^j UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^k Cliniques de l'Europe Site St Michel   (Belgium)

^l DEPARTMENT OF CARDIOLOGY   (Belgium)

^m UNIVERSITÉ DE BORDEAUX   (France)

ⁿ HAUT LÉVÊQUE HOSPITAL   (France)

more..

Author keywords

Acute kidney injury; Blood purification; High volume hemofiltration; Renal replacement therapy; Septic shock

Indexed keywords

ACUTE KIDNEY FAILURE; ADULT; AGED; BELGIUM; CARDIOEMBOLIC STROKE; CEREBROVASCULAR ACCIDENT; CONFERENCE PAPER; CONTROLLED STUDY; CRITICALLY ILL PATIENT; FEMALE; FRANCE; HEART INFARCTION; HEMOFILTRATION; HUMAN; HYPOKALEMIA; HYPOPHOSPHATEMIA; IATROGENIC DISEASE; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; MORTALITY; NETHERLANDS; OUTCOME ASSESSMENT; POSTOPERATIVE HEMORRHAGE; SEPTIC SHOCK;

ACUTE KIDNEY INJURY; AGED; CRITICAL ILLNESS; FEMALE; HEMOFILTRATION; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SHOCK, SEPTIC; SURVIVAL RATE; TIME FACTORS;

EID: 84881480919     PISSN: 03424642     EISSN: 14321238     Source Type: Journal    
DOI: 10.1007/s00134-013-2967-z     Document Type: Conference Paper

References (53)

1. Angus DC, Linde-Zwirble WT, Lidicker J et al (2001) Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 29:1303-1310
2. Bagshaw SM, Uchino S, Bellomo R et al (2007) Septic acute kidney injury in critically ill patients: clinical characteristics and outcomes. Clin J Am Soc Nephrol 2:431-439
3. Bernard GR, Vincent JL, Laterre PF et al (2001) Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 344:699-709
4. Opal SM, Laterre P-F, Francois B et al (2013) Effect of eritoran, an antagonist of MD2-TLR4, on mortality in patients with severe sepsis: the ACCESS randomized trial. JAMA J Am Med Assoc 309:1154-1162
5. Finfer S, Chittock DR, Su SY-S et al (2009) Intensive versus conventional glucose control in critically ill patients. N Engl J Med 360:1283-1297
6. Hoffmann JN, Hartl WH, Deppisch R et al (1996) Effect of hemofiltration on hemodynamics and systemic concentrations of anaphylatoxins and cytokines in human sepsis. Intensive Care Med 22:1360-1367
7. Heering P, Morgera S, Schmitz FJ et al (1997) Cytokine removal and cardiovascular hemodynamics in septic patients with continuous venovenous hemofiltration. Intensive Care Med 23:288-296
8. Bellomo R, Tipping P, Boyce N (1993) Continuous veno-venous hemofiltration with dialysis removes cytokines from the circulation of septic patients. Crit Care Med 21:522-526
9. Honore PM, Joannes-Boyau O (2004) High volume hemofiltration (HVHF) in sepsis: a comprehensive review of rationale, clinical applicability, potential indications and recommendations for future research. Int J Artif Organs 27:1077-1082
10. Rimmelé T, Kellum JA (2012) High-volume hemofiltration in the intensive care unit: a blood purification therapy. Anesthesiology 116:1377-1387
11. Rogiers P, Zhang H, Smail N et al (1999) Continuous venovenous hemofiltration improves cardiac performance by mechanisms other than tumor necrosis factor-alpha attenuation during endotoxic shock. Crit Care Med 27:1848-1855
12. Yekebas EF, Eisenberger CF, Ohnesorge H et al (2001) Attenuation of sepsis-related immunoparalysis by continuous veno-venous hemofiltration in experimental porcine pancreatitis. Crit Care Med 29:1423-1430
13. Wang H, Zhang ZH, Yan XW et al (2005) Amelioration of hemodynamics and oxygen metabolism by continuous venovenous hemofiltration in experimental porcine pancreatitis. World J Gastroenterol 11:127-131
14. Rimmelé T, Assadi A, Cattenoz M et al (2009) High-volume haemofiltration with a new haemofiltration membrane having enhanced adsorption properties in septic pigs. Nephrol Dial Transplant 24:421-427
15. Bellomo R, Kellum JA, Gandhi CR et al (2000) The effect of intensive plasma water exchange by hemofiltration on hemodynamics and soluble mediators in canine endotoxemia. Am J Respir Crit Care Med 161:1429-1436
16. Honore PM, Jamez J, Wauthier M et al (2000) Prospective evaluation of short-term, high-volume isovolemic hemofiltration on the hemodynamic course and outcome in patients with intractable circulatory failure resulting from septic shock. Crit Care Med 28:3581-3587
17. Joannes-Boyau O, Rapaport S, Bazin R et al (2004) Impact of high volume hemofiltration on hemodynamic disturbance and outcome during septic shock. ASAIO J 50:102-109
18. Cornejo R, Downey P, Castro R et al (2006) High-volume hemofiltration as salvage therapy in severe hyperdynamic septic shock. Intensive Care Med 32:713-722
19. Cole L, Bellomo R, Hart G et al (2002) A phase II randomized, controlled trial of continuous hemofiltration in sepsis. Crit Care Med 30:100-106
20. Cole L, Bellomo R, Journois D et al (2001) High-volume haemofiltration in human septic shock. Intensive Care Med 27:978-986
21. Ratanarat R, Brendolan A, Piccinni P et al (2005) Pulse high-volume haemofiltration for treatment of severe sepsis: effects on hemodynamics and survival. Crit Care 9:R294-R302
22. Boussekey N, Chiche A, Faure K et al (2008) A pilot randomized study comparing high and low volume hemofiltration on vasopressor use in septic shock. Intensive Care Med 34:1646-1653
23. Uchino S, Bellomo R, Morimatsu H et al (2007) Continuous renal replacement therapy: a worldwide practice survey. The beginning and ending supportive therapy for the kidney (B.E.S.T. kidney) investigators. Intensive Care Med 33:1563-1570
24. Vesconi S, Cruz DN, Fumagalli R et al (2009) Delivered dose of renal replacement therapy and mortality in critically ill patients with acute kidney injury. Crit Care 13:R57
25. Lee K, Lee SR, Mun CH, Min BG (2008) Pulse push/pull hemodialysis: in vitro study on new dialysis modality with higher convective efficiency. Artif Organs 32:406-411
26. Churchwell MD, Pasko DA, Btaiche IF et al (2007) Trace element removal during in vitro and in vivo continuous haemodialysis. Nephrol Dial Transplant 22:2970-2977
27. Bouman CS, van Kan HJ, Koopmans RP et al (2006) Discrepancies between observed and predicted continuous venovenous hemofiltration removal of antimicrobial agents in critically ill patients and the effects on dosing. Intensive Care Med 32:2013-2019
28. Klouche K, Cavadore P, Portales P et al (2002) Continuous veno-venous hemofiltration improves hemodynamics in septic shock with acute renal failure without modifying TNFalpha and IL6 plasma concentrations. J Nephrol 15:150-157
29. Kellum JA, Venkataraman R (2002) Blood purification in sepsis: an idea whose time has come? Crit Care Med 30:1387-1388
30. Joannes-Boyau O, Honore PM, Boer W (2006) Hemofiltration: the case for removal of sepsis mediators from where they do harm. Crit Care Med 34:2244-2246
31. Levy MM, Fink MP, Marshall JC et al (2003) 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 31:1250-1256
32. Bellomo R, Ronco C, Kellum JA et al (2004) Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 8:R204-R212
33. Pottecher T, Calvat S, Dupont H et al (2006) Haemodynamic management of severe sepsis: recommendations of the French Intensive Care Societies (SFAR/SRLF) Consensus Conference, 13 October 2005, Paris, France. Crit Care 10:311
34. Vincent JL, Moreno R, Takala J et al (1996) The SOFA (Sepsis-Related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med 22:707-710
35. Le Gall JR, Lemeshow S, Saulnier F (1993) A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. JAMA 270:2957-2963
36. Shore S, Nelson DP, Pearl JM et al (2001) Usefulness of corticosteroid therapy in decreasing epinephrine requirements in critically ill infants with congenital heart disease. Am J Cardiol 88:591-594
37. Wernovsky G, Wypij D, Jonas RA et al (1995) Postoperative course and hemodynamic profile after the arterial switch operation in neonates and infants. A comparison of low-flow cardiopulmonary bypass and circulatory arrest. Circulation 92:2226-2235
38. Zuppa AF, Nadkarni V, Davis L et al (2004) The effect of a thyroid hormone infusion on vasopressor support in critically ill children with cessation of neurologic function. Crit Care Med 32:2318-2322
39. Tsujimoto H, Ono S, Hiraki S et al (2004) Hemoperfusion with polymyxin B-immobilized fibers reduced the number of CD16+ CD14+ monocytes in patients with septic shock. J Endotoxin Res 10:229-237
40. Cruz DN, Antonelli M, Fumagalli R et al (2009) Early use of polymyxin B hemoperfusion in abdominal septic shock: the EUPHAS randomized controlled trial. JAMA 301:2445-2452
41. Parrillo JE (1993) Pathogenetic mechanisms of septic shock. N Engl J Med 328:1471-1477
42. Metnitz PG, Krenn CG, Steltzer H et al (2002) Effect of acute renal failure requiring renal replacement therapy on outcome in critically ill patients. Crit Care Med 30:2051-2058
43. Schrier RW, Wang W (2004) Acute renal failure and sepsis. N Engl J Med 351:159-169
44. Pocock S (1996) Clinical trials: a practical approach. Wiley, Canada
45. Hernandez AV, Eijkemans MJ, Steyerberg EW (2006) Randomized controlled trials with time-to-event outcomes: how much does prespecified covariate adjustment increase power? Ann Epidemiol 16:41-48
46. Zhang P, Yang Y, Lv R et al (2012) Effect of the intensity of continuous renal replacement therapy in patients with sepsis and acute kidney injury: a single-center randomized clinical trial. Nephrol Dial Transpl 27:967-973
47. Ronco C, Bellomo R, Homel P et al (2000) Effects of different doses in continuous veno-venous haemofiltration on outcomes of acute renal failure: a prospective randomised trial. Lancet 356:26-30
48. Bellomo R, Cass A, Cole L et al (2009) Intensity of continuous renal-replacement therapy in critically ill patients. N Engl J Med 361:1627-1638
49. Palevsky PM, Zhang JH, O'Connor TZ et al (2008) Intensity of renal support in critically ill patients with acute kidney injury. N Engl J Med 359:7-20
50. Bellomo R, Lipcsey M, Calzavacca P et al (2013) Early acid-base and blood pressure effects of continuous renal replacement therapy intensity in patients with metabolic acidosis. Intensive Care Med 39:429-436
51. Demirjian S, Teo BW, Guzman JA et al (2011) Hypophosphatemia during continuous hemodialysis is associated with prolonged respiratory failure in patients with acute kidney injury. Nephrol Dial Transpl 26:3508-3514
52. Roberts DM, Roberts JA, Roberts MS et al (2012) Variability of antibiotic concentrations in critically ill patients receiving continuous renal replacement therapy: a multicentre pharmacokinetic study. Crit Care Med 40:1523-1528
53. Payen D, Mateo J, Cavaillon JM et al (2009) Impact of continuous venovenous hemofiltration on organ failure during the early phase of severe sepsis: a randomized controlled trial. Crit Care Med 37:803-810